These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 48725)

  • 41. [Islet-cell antibodies in juvenile diabetes mellitus (author's transl)].
    Ludwig H; Schernthaner G; Mayr WR
    Dtsch Med Wochenschr; 1977 Aug; 102(34):1221-4. PubMed ID: 334498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta-cell damage in diabetic insulitis: are we approaching a solution?
    Bottazzo GF
    Diabetologia; 1984 Apr; 26(4):241-9. PubMed ID: 6376230
    [No Abstract]   [Full Text] [Related]  

  • 43. Current views on the etiology of insulin-dependent diabetes mellitus.
    Craighead JE
    N Engl J Med; 1978 Dec; 299(26):1439-45. PubMed ID: 362209
    [No Abstract]   [Full Text] [Related]  

  • 44. [Actual problems of diabetes mellitus].
    Balabolkin MI
    Sov Med; 1989; (11):3-7. PubMed ID: 2697087
    [No Abstract]   [Full Text] [Related]  

  • 45. [Autoimmunity and viral infections in type-I diabetes mellitus].
    Helmke K; Weimer R; Willems W; Otten A; Mäser E; Velcovsky HG; Federlin K
    Dtsch Med Wochenschr; 1986 Mar; 111(10):369-73. PubMed ID: 3512225
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens.
    Füchtenbusch M; Kredel K; Bonifacio E; Schnell O; Ziegler AG
    Diabetes; 2000 Jun; 49(6):918-25. PubMed ID: 10866043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HLA and pancreatic islet cell antibodies in diabetes.
    Morris PJ; Irvine WJ; Gray RS; Duncan LJ; Vaughan H; McCallum FJ; Campbell CJ; Farquhar JW
    Lancet; 1976 Sep; 2(7987):652-3. PubMed ID: 60516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-dependent diabetes: a disease of autoaggression.
    Huang SW; Maclaren NK
    Science; 1976 Apr; 192(4234):64-6. PubMed ID: 769160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pillars Article: Antibodies to Pancreatic Islet Cells in Insulin-dependent Diabetics with Coexistent Autoimmune Disease.
    MacCuish AC; Irvine WJ; Barnes EW; Duncan LJP
    J Immunol; 2017 Nov; 199(9):3019-3021. PubMed ID: 29061713
    [No Abstract]   [Full Text] [Related]  

  • 51. Characterization of islet cell antibody in insulin dependent diabetes: evidence for IgG1 subclass restriction and polyclonality.
    Millward A; Hussain MJ; Peakman M; Pyke DA; Leslie RD; Vergani D
    Clin Exp Immunol; 1988 Feb; 71(2):353-6. PubMed ID: 3127094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complement activation in diabetes mellitus.
    Bergamaschini L; Gardinali M; Poli M; Lorini R; Bosi E; Agostoni A
    J Clin Lab Immunol; 1991 Jul; 35(3):121-7. PubMed ID: 1688167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin autoantibodies (IAA) may cause false positive islet cell antibody (ICA) results in the indirect immunofluorescence test.
    Scott-Morgan L; Keller U; Heitz P; Mirza I; Diaz JL; Casey C; Wilkin T
    Diabetes Res; 1988 May; 8(1):45-8. PubMed ID: 3066565
    [No Abstract]   [Full Text] [Related]  

  • 54. Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type.
    Irvine WJ; McCallum CJ; Gray RS; Campbell CJ; Duncan LJ; Farquhar JW; Vaughan H; Morris PJ
    Diabetes; 1977 Feb; 26(2):138-47. PubMed ID: 320073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents.
    Irvine WJ; McCallum CJ; Gray RS; Duncan LJ
    Lancet; 1977 May; 1(8020):1025-7. PubMed ID: 67485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of an immunohistochemical and immunofluorescence procedure to detect antibody to pancreatic islet cells.
    Krell J; Rabin BS
    Diabetes; 1984 Aug; 33(8):709-11. PubMed ID: 6204895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal autoantibodies from insulin-dependent diabetic patients: autoantibodies against beta-cell surface or cytoplasmic antigens.
    Houssaint E; Pogu S; Ouary M; Sai P
    Clin Exp Immunol; 1990 Oct; 82(1):44-51. PubMed ID: 1698582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of islet cell autoantibodies in newly diagnosed diabetic patients using insulin-producing Syrian hamster cells.
    Matsuba I; Marner B; Nerup J; Lernmark A
    Diabetes Res; 1987 Mar; 4(3):103-7. PubMed ID: 3301157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
    Ongagna JC; Levy-Marchal C
    Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complement-fixing Islet cell antibodies from some diabetic patients alter insulin release in vitro.
    Sai P; Boitard C; Debray-Sachs M; Pouplard A; Assan R; Hamburger J
    Diabetes; 1981 Dec; 30(12):1051-7. PubMed ID: 7030831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.